Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 342

1.

Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on "number of patients needed to transplant" as measure of transplant benefit.

Vitale A, Cucchetti A, Qiao GL, Cescon M, Li J, Ramirez Morales R, Frigo AC, Xia Y, Tuci F, Shen F, Cillo U, Pinna AD.

J Hepatol. 2014 Jun;60(6):1165-71. doi: 10.1016/j.jhep.2014.01.022.

PMID:
24508550
2.

Survival Benefit of Liver Transplantation Versus Resection for Hepatocellular Carcinoma: Impact of MELD Score.

Vitale A, Huo TL, Cucchetti A, Lee YH, Volk M, Frigo AC, Cescon M, Tuci F, Pinna AD, Cillo U.

Ann Surg Oncol. 2015;22(6):1901-7. doi: 10.1245/s10434-014-4099-2.

PMID:
25234023
3.

Predicting survival after liver transplantation using up-to-seven criteria in patients with hepatocellular carcinoma.

de Ataide EC, Garcia M, Mattosinho TJ, Almeida JR, Escanhoela CA, Boin IF.

Transplant Proc. 2012 Oct;44(8):2438-40. doi: 10.1016/j.transproceed.2012.07.006.

PMID:
23026614
4.

Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?

Adam R, Azoulay D, Castaing D, Eshkenazy R, Pascal G, Hashizume K, Samuel D, Bismuth H.

Ann Surg. 2003 Oct;238(4):508-18; discussion 518-9.

5.

Role of surgical resection for multiple hepatocellular carcinomas.

Choi SH, Choi GH, Kim SU, Park JY, Joo DJ, Ju MK, Kim MS, Choi JS, Han KH, Kim SI.

World J Gastroenterol. 2013 Jan 21;19(3):366-74. doi: 10.3748/wjg.v19.i3.366.

6.

Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis.

Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, Camerini T, Roayaie S, Schwartz ME, Grazi GL, Adam R, Neuhaus P, Salizzoni M, Bruix J, Forner A, De Carlis L, Cillo U, Burroughs AK, Troisi R, Rossi M, Gerunda GE, Lerut J, Belghiti J, Boin I, Gugenheim J, Rochling F, Van Hoek B, Majno P; Metroticket Investigator Study Group..

Lancet Oncol. 2009 Jan;10(1):35-43. doi: 10.1016/S1470-2045(08)70284-5.

PMID:
19058754
7.

Results of salvage liver transplantation.

Guerrini GP, Gerunda GE, Montalti R, Ballarin R, Cautero N, De Ruvo N, Spaggiari M, Di Benedetto F.

Liver Int. 2014 Jul;34(6):e96-e104. doi: 10.1111/liv.12497.

PMID:
24517642
8.

Outcome after partial hepatectomy for hepatocellular cancer within the Milan criteria.

Fan ST, Poon RT, Yeung C, Lam CM, Lo CM, Yuen WK, Ng KK, Liu CL, Chan SC.

Br J Surg. 2011 Sep;98(9):1292-300. doi: 10.1002/bjs.7583.

PMID:
21656513
9.

The survival benefit of liver transplantation for hepatocellular carcinoma patients with hepatitis B virus infection and cirrhosis.

Zhang Q, Chen X, Zang Y, Zhang L, Chen H, Wang L, Niu Y, Ren X, Shen Z, Shang L.

PLoS One. 2012;7(12):e50919. doi: 10.1371/journal.pone.0050919.

10.

Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria.

Hameed B, Mehta N, Sapisochin G, Roberts JP, Yao FY.

Liver Transpl. 2014 Aug;20(8):945-51. doi: 10.1002/lt.23904.

11.

Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation.

Margarit C, Escartín A, Castells L, Vargas V, Allende E, Bilbao I.

Liver Transpl. 2005 Oct;11(10):1242-51.

12.
13.

Serum C-reactive protein is a useful biomarker for predicting outcomes after liver transplantation in patients with hepatocellular carcinoma.

An HJ, Jang JW, Bae SH, Choi JY, Yoon SK, Lee MA, You YK, Kim DG, Jung ES.

Liver Transpl. 2012 Dec;18(12):1406-14. doi: 10.1002/lt.23512.

14.

The role of living-donor liver transplantation in surgical treatment for hepatocellular carcinoma.

Yokoi H, Isaji S, Yamagiwa K, Tabata M, Nemoto A, Sakurai H, Usui M, Uemoto S.

J Hepatobiliary Pancreat Surg. 2006;13(2):123-30.

PMID:
16547673
15.

Cirrhosis and microvascular invasion predict outcomes in hepatocellular carcinoma.

Barreto SG, Brooke-Smith M, Dolan P, Wilson TG, Padbury RT, Chen JW.

ANZ J Surg. 2013 May;83(5):331-5. doi: 10.1111/j.1445-2197.2012.06196.x.

PMID:
22943449
16.

Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.

Hanouneh IA, Macaron C, Lopez R, Aucejo F, Zein NN.

Transplant Proc. 2011 Dec;43(10):3813-8. doi: 10.1016/j.transproceed.2011.09.043.

PMID:
22172852
17.

A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.

Agopian VG, Harlander-Locke M, Zarrinpar A, Kaldas FM, Farmer DG, Yersiz H, Finn RS, Tong M, Hiatt JR, Busuttil RW.

J Am Coll Surg. 2015 Apr;220(4):416-27. doi: 10.1016/j.jamcollsurg.2014.12.025.

PMID:
25690672
18.

Survival after radiofrequency ablation and salvage transplantation in patients with hepatocellular carcinoma and Child-Pugh A cirrhosis.

N'Kontchou G, Aout M, Laurent A, Nahon P, Ganne-Carrié N, Grando V, Baghad I, Roulot D, Trinchet JC, Sellier N, Cherqui D, Vicaut E, Beaugrand M, Seror O.

J Hepatol. 2012 Jan;56(1):160-6. doi: 10.1016/j.jhep.2011.03.026.

PMID:
21703186
19.

A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.

Vitale A, Volk ML, De Feo TM, Burra P, Frigo AC, Ramirez Morales R, De Carlis L, Belli L, Colledan M, Fagiuoli S, Rossi G, Andorno E, Baccarani U, Regalia E, Vivarelli M, Donataccio M, Cillo U; Liver Transplantation North Italy Transplant program (NITp) working group..

J Hepatol. 2014 Feb;60(2):290-7. doi: 10.1016/j.jhep.2013.10.010. Erratum in: J Hepatol. 2014 Jun;60(6):1336. Multiple investigator names added.

PMID:
24161408
20.

Utility-based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha-fetoprotein model as a survival predictor.

Vitale A, Farinati F, Burra P, Trevisani F, Giannini EG, Ciccarese F, Piscaglia F, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Borzio F, Cabibbo G, Felder M, Sacco R, Morisco F, Missale G, Foschi FG, Gasbarrini A, Svegliati Baroni G, Virdone R, Chiaramonte M, Spolverato G, Cillo U; Italian Liver Cancer Group..

Liver Transpl. 2015 Oct;21(10):1250-8. doi: 10.1002/lt.24214.

Items per page

Supplemental Content

Support Center